A Study of KRN23 in X-linked Hypophosphatemia



Status:Archived
Conditions:Other Indications, Metabolic
Therapuetic Areas:Pharmacology / Toxicology, Other
Healthy:No
Age Range:Any
Updated:7/1/2011
Start Date:December 2008
End Date:July 2011

Use our guide to learn which trials are right for you!

Trial Summary
Trial Overview
Inclusion Criteria

A Phase I, Double-blind, Randomized, Placebo-controlled, Single-dose, Dose-escalation Study of KRN23 in X-linked Hypophosphatemia


The primary objective of this study is to assess the safety and tolerability of KRN23 after
a single intravenous (IV) and subcutaneous (SC) administration in XLH patients.



We found this trial at
4
sites
University of Texas Health Science Center at Houston
7000 Fannin St
Houston, Texas 77030
(713) 500-4472
University of Texas Health Science Center at Houston The University of Texas Health Science Center...
990
mi
from 43215
Houston, TX
Click here to add this to my saved trials
Duke Univ Med Ctr
2301 Erwin Rd
Durham, North Carolina 27710
919-684-8111
Duke Univ Med Ctr As a world-class academic and health care system, Duke Medicine strives...
352
mi
from 43215
Durham, NC
Click here to add this to my saved trials
General Clinical Research Center, Indiana University School of Medicine
Indianapolis, Indiana 46202
166
mi
from 43215
Indianapolis, IN
Click here to add this to my saved trials
Yale University School of Medicine
333 Cedar St
New Haven, Connecticut 06504
(203) 432-4771
Yale University School of Medicine Founded in 1810, the Yale School of Medicine is a...
537
mi
from 43215
New Haven, CT
Click here to add this to my saved trials